ReviewPLoS medicine2007
Ghost management: how much of the medical literature is shaped behind the scenes by the pharmaceutical industry?
Review in PLoS medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Pooled it
- The nature and influence of pharmaceutical industry involvement in asthma trials.Canadian respiratory journalPooled it
- Knowledge of undisclosed corporate authorship ("ghostwriting") reduces the perceived credibility of antidepressant research: a randomized vignette study with experienced nurses.BMC research notes · 2012Trial
- Purdue's development of abuse-deterrent formulation opioids as a response to market competition: An industry documents analysis.SSM. Qualitative research in health · 2026Article
- A portrait of commissioned literature: connecting the dots between medical education and communication companies, authors, funders and publishers.Research integrity and peer review · 2026Article
- How big is the medical writing industry? Why it matters.Health promotion international · 2025Article
- Article
- Article
- Beyond Bias: Aggregate Approaches to Conflicts of Interest Research and Policy in Biomedical Research.World medical & health policy · 2024Article
- What did the scientific literature learn from internal company documents in the pharmaceutical industry? A scoping review.Cochrane evidence synthesis and methods · 2023Review
- Off-Label Use vs Off-Label Marketing: Part 2: Off-Label Marketing-Consequences for Patients, Clinicians, and Researchers.JACC. Basic to translational science · 2023Article
- Why psychiatry needs an honest dose of gentle medicine.Frontiers in psychiatry · 2023Review
- Affordable and underutilized: the paradox of surgical castration.Translational andrology and urology · 2022Article
- Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.Journal of general internal medicine · 2022Article
- Are Corporations Re-Defining Illness and Health? The Diabetes Epidemic, Goal Numbers, and Blockbuster Drugs.Journal of bioethical inquiry · 2021Review
- Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them.Journal of medical ethics · 2021Review
- Allonymous science: the politics of placing and shifting credit in public-private nutrition research.Life sciences, society and policy · 2020Article
- Relationships among commercial practices and author conflicts of interest in biomedical publishing.PloS one · 2020Article
- Open Science for private Interests? How the Logic of Open Science Contributes to the Commercialization of Research.Frontiers in research metrics and analytics · 2020Article
- Corporate Logic in Clinical Care: The Case of Diabetes Management.Medical anthropology quarterly · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.